Peter Ellmark
- Immunology top 5%
- Immunotherapy and Immune Responses 26
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 7
- Oncology top 5%
- CAR-T cell therapy research 27
- Cancer Immunotherapy and Biomarkers 27
-
- Monoclonal and Polyclonal Antibodies Research 29
-
- Advanced Biosensing Techniques and Applications 11
- Glycosylation and Glycoproteins Research 10
- Co-authors
- Carl BorrebaeckSara M. MangsboThomas H. TöttermanChrister WingrenJohan IngvarssonPer NorlénChristina FurebringAnders Carlsson
- Journals
- Cancer Research (7 papers)Cancer Immunology Immunotherapy (4 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- SwedenUnited StatesFrance
In The Last Decade
Peter Ellmark
58 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 73
- Immunology 610
- Oncology 598
- Radiology, Nuclear Medicine and Imaging 342
- Molecular Biology 492
- Biomedical Engineering 218
Countries citing papers authored by Peter Ellmark
This map shows the geographic impact of Peter Ellmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellmark more than expected).
Fields of papers citing papers by Peter Ellmark
This network shows the impact of papers produced by Peter Ellmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellmark. The network helps show where Peter Ellmark may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Ellmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 23 | |
| 3 | 2023 | 6 | |
| 4 | 2017 | 25 | |
| 5 | 2015 | 16 | |
| 6 | 2014 | 84 | |
| 7 | 2013 | 81 | |
| 8 | 2009 | 10 | |
| 9 | 2008 | 3 | |
| 10 | 2008 | 7 | |
| 11 | 2008 | 95 | |
| 12 | 2008 | 119 | |
| 13 | 2008 | 7 | |
| 14 | 2008 | 96 | |
| 15 | High-throughput membrane proteomics using recombinant antibody microarrays | 2006 | 2 |
| 16 | 2006 | 51 | |
| 17 | 2006 | 90 | |
| 18 | 2004 | 6 | |
| 19 | 2002 | 17 | |
| 20 | 2002 | 11 |
About Peter Ellmark
Peter Ellmark is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (29 papers), CAR-T cell therapy research (27 papers), Cancer Immunotherapy and Biomarkers (27 papers), Immunotherapy and Immune Responses (26 papers), Advanced Biosensing Techniques and Applications (11 papers), Glycosylation and Glycoproteins Research (10 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Immunology (610 citations), Oncology (598 citations) and Radiology, Nuclear Medicine and Imaging (342 citations). Peter Ellmark has collaborated with scholars based in Sweden, United States and France. Frequent co-authors include Carl Borrebaeck, Sara M. Mangsbo, Thomas H. Tötterman, Christer Wingren, Johan Ingvarsson, Per Norlén, Christina Furebring, Anders Carlsson, Linda C. Sandin and Niina Veitonmäki. Their work appears in journals such as Cancer Research, Cancer Immunology Immunotherapy, Journal of Clinical Oncology, OncoImmunology and PROTEOMICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.